Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-2.8x
Contraction
Streak
2 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | -46.53% |
| Q3 2025 | -46.18% |
| Q2 2025 | 10.10% |
| Q1 2025 | -97.53% |
| Q4 2024 | -14.24% |
| Q3 2024 | -1.86% |
| Q2 2024 | 41.33% |
| Q1 2024 | -339.83% |
| Q4 2023 | 43.56% |
| Q3 2023 | -125.49% |
| Q2 2023 | 46.49% |
| Q1 2023 | 25.30% |
| Q4 2022 | 30.68% |
| Q3 2022 | 2.92% |
| Q2 2022 | -16.55% |
| Q1 2022 | -6.28% |
| Q4 2021 | 8.37% |
| Q3 2021 | -63.68% |
| Q2 2021 | 42.66% |
| Q1 2021 | -61.79% |
| Q4 2020 | 16.54% |
| Q3 2020 | -7.02% |
| Q2 2020 | 16.55% |
| Q1 2020 | -54.73% |
| Q4 2019 | 3.15% |
| Q3 2019 | 6.92% |
| Q2 2019 | 10.37% |
| Q1 2019 | -78.12% |
| Q4 2018 | 22.90% |
| Q3 2018 | -30.69% |
| Q2 2018 | 23.77% |
| Q1 2018 | -21.80% |
| Q4 2017 | -4.47% |
| Q3 2017 | 78.07% |
| Q2 2017 | -38.48% |
| Q1 2017 | -30.13% |
| Q4 2016 | 27.47% |
| Q3 2016 | 17.13% |
| Q2 2016 | -55.46% |
| Q1 2016 | -66881.37% |